[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533001":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":27,"locations":37,"responsibleParty":59,"collaborators":10,"id":62,"slug":10,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":74,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":80,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Ankara University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"single group",null,"rocuronium drug administration TOFscan monitoring administration of sugammadex drug recording of classical TOF and modified TOF values",[13],"Device: TOFscan monitoring",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","TOFscan monitoring","observation and data recording",[9],[21,24],{"name":22,"affiliation":5,"role":23},"Menekşe Özçelik, 1","STUDY_DIRECTOR",{"name":25,"affiliation":5,"role":26},"Hatice Güneş Yeşilova, 2","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Hatice Güneş Yeşilova, 1","CONTACT","+905510495354","htcguness@hotmail.com",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},"Menekşe Özçelik, 2","+905333521400","mozcelik@ankara.edu.tr",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":10,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Ankara","Altındağ","06230","Turkey (Türkiye)",{"type":45,"coordinates":46},"Point",[47,48],32.85427,39.91987,{"lat":48,"lon":47},[51,54,55,58],{"name":52,"role":30,"phone":53,"phoneExt":10,"email":32},"Hatice Gunes, 1","+90 551 049 53 54",{"name":10,"role":30,"phone":10,"phoneExt":10,"email":32},{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Hatice Güneş, 1","SUB_INVESTIGATOR",{"name":22,"role":26,"phone":10,"phoneExt":10,"email":10},{"type":26,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Hatice Güneş Yeşilova, MD","Research assistant","100533001",false,"NCT06220136","Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex","Comparison of the Performances of the Train-of-Four Ratio and the Modified Train-of-Four Ratio During Reversal of Deep Neuromuscular Blockade With Sugammadex","Inclusion Criteria:\n\n* Age: 18 - 65 (not including 65)\n* BMI: 18.5-24.9\n\nExclusion Criteria:\n\n* Liver and kidney disease\n* Non-consenting\n* Emergency surgeries\n* Muscle disease\n* Allergy to rocuronium and sugammadex\n* Patients predicted to have difficult mask ventilation or difficult intubation\n* Pregnant and breastfeeding women","ALL","18 Years","65 Years",{"count":72,"type":73},199,"ESTIMATED","6 Months","OBSERVATIONAL","It is known that deep neuromuscular block improves surgical conditions, especially during laparoscopic abdominal surgery. Based on this, in the Perioperative Neuromuscular Blockade Management guide published by the ESAIC association in 2022, it is recommended to deepen the level of neuromuscular blockade in cases where surgical conditions need to be improved. Sugammadex should be used to quickly and reliably reverse deep neuromuscular blockade. TOFScan, a 3-dimensional acceleromyograph for neuromuscular monitoring, has become widely used in recent years. With this monitor, it has been shown that in addition to the classical train-of-four ratio (cTOFR), the modified train-of-four ratio (mTOFR) can be used during the spontaneous recovery of nondepolarizing neuromuscular blockade. In a study conducted by Schmartz et al. in 2021, it was shown that mTOFR, which is the ratio of T4 to the reference stimulus, was compiled later than cTOFR. Therefore, it is suggested that the mTOFR value is a better determinant for safe extubation.",[78,79],"Neuromuscular Blockade","Anesthesia, General",[81,82,83,84],"neuromuscular blockade","neuromuscular junction monitoring","TOFscan","modified TOF ratio","2026-02-11",{"date":87,"type":88},"2026-02-12","ACTUAL",{"date":90,"type":88},"2024-06-01",{"date":92,"type":73},"2026-06-01",{"name":5,"class":6},1]